Evaluación de la calidad de las guías de práctica clínica sobre encefalopatía hipóxica-isquémica en recién nacidos entre los años 2013 a 2022 mediante la herramienta AGREE ii: una revisión de alcance

Abstract

Introduction

Hypoxic-ischaemic encephalopathy is a clinical syndrome of neurological dysfunction that occurs immediately after birth following an episode of perinatal asphyxia. We conducted a scoping review to assess the methodological quality of clinical practice guidelines that address this condition.

Methodology

We conducted the evaluation using the AGREE II tool. High methodological quality was defined as a score greater than 70% in every domain.

Results

The analysis included three clinical practice guidelines; the highest scores were in the scope and purpose domain (84.26%; SD, 14.25%) and the clarity of presentation domain (84.26%; SD, 17.86%), while the lowest score corresponded to the applicability domain (62.50%; SD, 36.62%). Two guidelines were classified as high quality and one guideline as low-quality.

Conclusions

Two of the assessed guidelines were classified as being of high quality; however, the analysis identified shortcomings in the applicability domain, in addition to methodological variation between guidelines developed in middle- or low-income countries versus high-income countries. Efforts are needed to make high-quality guidelines available to approach the management of hypoxic-ischaemic encephalopathy in newborns.